#lantus — Public Fediverse posts

Here's the latest example to cross my path: the #FTC has intervened in a lawsuit over generic insulin pricing, on an issue that is incredibly technically specific and also fantastically important:

https://www.fiercepharma.com/pharma/ftc-blasts-pharmas-abuse-fda-patent-system-sanofi-mylans-insulin-monopoly-lawsuit

The underlying case is before the FDA, and it concerns the dirty tricks that pharma giant #Sanofi used to keep #Mylan from making a generic version of Mylan's #Lantus insulin after its patent expired.

17/

Here's the latest example to cross my path: the #FTC has intervened in a lawsuit over generic insulin pricing, on an issue that is incredibly technically specific and also fantastically important:

https://www.fiercepharma.com/pharma/ftc-blasts-pharmas-abuse-fda-patent-system-sanofi-mylans-insulin-monopoly-lawsuit

The underlying case is before the FDA, and it concerns the dirty tricks that pharma giant #Sanofi used to keep #Mylan from making a generic version of Mylan's #Lantus insulin after its patent expired.

17/

Here's the latest example to cross my path: the #FTC has intervened in a lawsuit over generic insulin pricing, on an issue that is incredibly technically specific and also fantastically important:

https://www.fiercepharma.com/pharma/ftc-blasts-pharmas-abuse-fda-patent-system-sanofi-mylans-insulin-monopoly-lawsuit

The underlying case is before the FDA, and it concerns the dirty tricks that pharma giant #Sanofi used to keep #Mylan from making a generic version of Mylan's #Lantus insulin after its patent expired.

17/

Here's the latest example to cross my path: the #FTC has intervened in a lawsuit over generic insulin pricing, on an issue that is incredibly technically specific and also fantastically important:

https://www.fiercepharma.com/pharma/ftc-blasts-pharmas-abuse-fda-patent-system-sanofi-mylans-insulin-monopoly-lawsuit

The underlying case is before the FDA, and it concerns the dirty tricks that pharma giant #Sanofi used to keep #Mylan from making a generic version of Mylan's #Lantus insulin after its patent expired.

17/

Here's the latest example to cross my path: the #FTC has intervened in a lawsuit over generic insulin pricing, on an issue that is incredibly technically specific and also fantastically important:

https://www.fiercepharma.com/pharma/ftc-blasts-pharmas-abuse-fda-patent-system-sanofi-mylans-insulin-monopoly-lawsuit

The underlying case is before the FDA, and it concerns the dirty tricks that pharma giant #Sanofi used to keep #Mylan from making a generic version of Mylan's #Lantus insulin after its patent expired.

17/